Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Naveen K. Krishnegowda"'
Autor:
Hareesh B Nair, Bindu Santhamma, Naveen K Krishnegowda, Kalarikkal V Dileep, Klaus J Nickisch
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151182 (2016)
Use of estrogen or estrogen/progestin combination was an approved regimen for menopausal hormonal therapy (MHT). However, more recent patient-centered studies revealed an increase in the incidence of breast cancer in women receiving menopausal hormon
Externí odkaz:
https://doaj.org/article/af532240aaac41fd840aff5c551d9b81
Autor:
Rajeshwar Rao Tekmal, A Thurlapati, Naveen K. Krishnegowda, Kumaraguruparan Ramasamy, Ratna K. Vadlamudi, Cathy Samayoa
Publikováno v:
Cancer Research. 79:P1-04
Breast Cancer is the main cause of cancer-associated mortality in women worldwide. The estrogen receptors (ER's) play an important role in normal mammary gland development, as well as in breast cancer. Estrogen Receptor α is expressed in 70% of brea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::200a1af43c9ba15deef744554bca2d87
https://doi.org/10.1158/1538-7445.sabcs18-p1-04-01
https://doi.org/10.1158/1538-7445.sabcs18-p1-04-01
Autor:
Ratna K. Vadlamudi, Rajeshwar Rao Tekmal, Cathy Samayoa, Naveen K. Krishnegowda, Kumaraguruparan Ramasamy
Publikováno v:
Cancer Research. 78:P1-09
Estrogen plays an important role in the initiation and progression of breast cancer (BCa). Approximately, 70% of breast tumors are estrogen receptor (ER) positive at the time of presentation. Endocrine therapy using aromatase inhibitors (AI), or anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5fa1db7fcdb0448254ae0866a81e3d9
https://doi.org/10.1158/1538-7445.sabcs17-p1-09-09
https://doi.org/10.1158/1538-7445.sabcs17-p1-09-09
Publikováno v:
Cancer Research. 77:P6-11
Breast Cancer is the primary cause of cancer-associated mortality worldwide, and in United States alone, more than 250,000 women are diagnosed every year. Current breast cancer treatment strategies focus on Estrogen Receptor α signaling, given that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e6963626e7a75751e8d0648fc436f42
https://doi.org/10.1158/1538-7445.sabcs16-p6-11-15
https://doi.org/10.1158/1538-7445.sabcs16-p6-11-15
Publikováno v:
Cancer Research. 77:P4-15
Breast cancer is the most common cancer among women worldwide. In the United States, 1 in 8 women will develop breast cancer during her lifetime, and in 2016 over 240,000 new cases will be diagnosed. Incidence rates differ by geographic location, wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::074e9349a09a1bf694351303d479ec37
https://doi.org/10.1158/1538-7445.sabcs16-p4-15-02
https://doi.org/10.1158/1538-7445.sabcs16-p4-15-02
Autor:
Rajeshwar Rao Tekmal, Alexandria M. Hertz, Edward R. Kost, Naveen K. Krishnegowda, Nicole D. Riddle, Kevin L. Hall, Philip T. Valente, Barnard A. Lynch
Publikováno v:
International Journal of Gynecologic Cancer. 26:1129-1136
ObjectivesApproximately 3% to 5% of endometrial cancers (EC) are associated with Lynch syndrome (LS). The clinical characteristics and prevalence of LS have not been well studied in the US Hispanic population. Hispanics are the largest and fastest gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f720ccfb2075daad1d1421579aec885
https://doi.org/10.1097/igc.0000000000000713
https://doi.org/10.1097/igc.0000000000000713
Breast cancer is one of the most common cancers in the world. The majority of breast cancers express estrogen receptor (ER)α, and endocrine therapy is the primary therapeutic approach to treat ER positive breast cancers. However, developing resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::652e4324678a5d7d8c500dff8945012e
https://doi.org/10.1016/bs.pmbts.2017.08.002
https://doi.org/10.1016/bs.pmbts.2017.08.002
Publikováno v:
Cancer Research. 73:P5-09
Estrogen receptors (ER) play an important role in breast cancer. Over two-thirds of all breast cancers express ERa, and current endocrine therapies target its signaling. Antiestrogens (AE) block the binding of estrogen to ERα, while aromatase inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9625bd4217a2ec63bbbb5a2438d633a2
https://doi.org/10.1158/0008-5472.sabcs13-p5-09-14
https://doi.org/10.1158/0008-5472.sabcs13-p5-09-14
Autor:
Shylesh Bhaskaran, Hareesh B. Nair, Mitch Klausner, Sathyaseelan S. Deepa, Naveen K. Krishnegowda, Chittalakkottu Sadasivan, Kalarikkal V. Dileep, Rajeshwar Rao Tekmal, John L. VandeBerg
Publikováno v:
Molecular Cancer Therapeutics. 12:361-372
Mutation in the BRAF gene (BRAFV600E) exists in nearly 70% of human melanomas. Targeted therapy against BRAFV600E kinase using a recently identified RAF-selective inhibitor, PLX4032, has been successful in early clinical trials. However, in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96c16384747c9fc0886a64adb5bb33ee
https://doi.org/10.1158/1535-7163.mct-12-0965
https://doi.org/10.1158/1535-7163.mct-12-0965
Autor:
Stacy M. Stephenson, Amanda Vasquez, Ramaswamy Sharma, Teja Guda, Joseph C. Wenke, Joel E. Michalek, Shiliang Chang, David E. Sahar, Naveen K. Krishnegowda, Son C. Nguyen, Howard T. Wang, Agustin Cornejo
Publikováno v:
Tissue Engineering Part A. 18:1552-1561
The use of processed bone allograft to repair large osseous defects of the skull has been limited, given that it lacks the osteogenic cellularity and intrinsic vascular supply which are essential elements for successful graft healing and, at the same
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98909eab81cfc7ee7f2f8a750c8f1c46
https://doi.org/10.1089/ten.tea.2011.0515
https://doi.org/10.1089/ten.tea.2011.0515